CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Candida - female genital - Management
Topical imidazoles
- Topical products containing imidazoles (clotrimazole, miconazole, and econazole) may damage latex condoms and diaphragms [BNF 53, 2007].
- Local mild burning or irritation may occur on application of vaginal imidazole pessaries and creams. Very rarely the woman may find this intolerable and discontinue treatment.
Basis for recommendation
- The fatty excipients in topical antifungal products may damage latex condoms and diaphragms [Spence, 2006].
© NHS Institute for Innovation and Improvement